Search Results
22 items found for "Victoria H Wu"
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology
- Nanobodies: New Dimensions in GPCR Signaling Research
This year Arum Wu et al. reported a library of Nbs to study the allosteric modulation of the rhodopsin H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. O., Ploegh, H. L., & Garcia, K. C. (2015). Structural biology. Science (New York, N.Y.), 347(6226), 1113–1117. https://doi.org/10.1126/science.aaa5026 Wu, A., Salom
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
peroxidase enzyme that catalyzes the oxidation of specific substrates in the presence of hydrogen peroxide (H When AUR is oxidized by APEX2 in the presence of H 2 O 2 , it produces a fluorescent product that can
- From DNA day to GPCR genomics
., Dohlman, H. G., Frielle, T., Bolanowski, M. A., Bennett, C. D., Rands, E., Diehl, R. G., & Schiöth, H. B. (2003). M., Pérez-Hernández, G., Batebi, H., Gao, Y., Eskici, G., Seven, A.
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
Unlike LGR2 in other insect species, HLGR2 was found to play a crucial role in the control of H. cunea Conclusion: HLGR2 is essential for the growth and development and wing expansion and maturation in H.
- Odorant receptors – a bit of smell for drug discovery
than 60 ORs in the testis and only a few ORs in the liver (Flegel C. et al. 2013; Maßberg D. and Hatt H. although there are highly increased in prostate tissue, especially in prostate cancer (Maßberg D. and Hatt H. olfactory-specific chaperones to be correctly targeted to the surface of heterologous cells (Maßberg D. and Hatt H.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
References Eishingdrelo, H., & Kongsamut, S. (2013). Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R.
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
will facilitate further development of therapeutic agents targeting the DOR.Communicated by Ramaswamy H.
- Decoding β-Arrestins: from Structure to function
F et al. 2021, Chen, H. et al. 2022). H., & Lee, J. H. 2020, Casiraghi, M. et al. 2019), double electron-electron resonance (DEER) spectroscopy for high-resolution
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
expression, restoration to ≥57% of WT levels was achieved for 6 by treatment with 1 µM CAN1404 for 24 h,
- Do You Believe AI Could Accelerate Drug Discovery?
Of 161 molecules tested, 42 substituted more than 50% of [³H]-LSD at 10 μM, achieving a 26% hit rate.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
October 21st to 27th, 2024 Industry News UNC School of Medicine to Receive $3-Million Award from ARPA-H’
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Nature chemical biology, 5(10), 734–742. https://doi.org/10.1038/nchembio.206 Wei, H., Ahn, S., Shenoy Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
"We are happy to announce you our 2nd IRN i-GPCRnet meeting that will be held at the University of Wurzburg
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
their fantastic work on Germline mutations in a G protein identify signaling cross-talk in T cells Victoria
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Zhang, H., et al., Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
H., Heydenreich, F. M., Kawakami, K., Masureel, M., Maeda, S., Garcia, K.
- Overview of adhesion GPCRs self-activation
., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen, Z., Huang, Z., & He, Y. (2022).
- Ode to GPCRs
George H. Edmond H.
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
of a small protein GPCR ligand using new peptide chemistry technology and rational design Gaertner, H.
- 📰 GPCR Weekly News, July 10 to 16, 2023
Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Confo Therapeutics CEO, Cedric Ververken, will join WuXi